Description
Diab contains the active substance gliclazide, one of a group of medicines called sulfonylureas. It is an oral hypoglycaemic medicine (blood sugar lowering drug).
Indications
Diab is used to keep blood sugar at the correct level in adults with non-insulin dependent diabetes when it is not controlled by diet, physical exercise and weight loss alone.
Subject to medical prescription.
Concentration and pharmaceutical form: 80 mg tablets
Description
HypoDehydra belongs to a class of medicines called “diuretics”. Diuretics increase the amount of water excreted in the urine.
Indications
HypoDehydra tablets are indicated for the treatment of the following in adults:
– edema of cardiac or renal origin;
– arterial hypertension;
– edema of hepatic origin, usually in combination with a potassium-sparing diuretic.
Subject to medical prescription.
Concentration and pharmaceutical form: 25 mg tablets
Description
Verapamil-Tchaikapharma supresses the amount of calcium getting into the muscle cells in heart and blood vessels. This can change the strength and speed with which your heart beats. It also opens up the blood vessels so blood can be pumped around the body more easily. This helps more oxygen to get to your heart muscle and can lower your blood pressure.
Indications
Verapamil-Tchaikapharma is indicated for treatment of myocardial ischaemia (conditions characterized by insufficient oxygen supply to the heart muscle), including:
-chronic stable angina pectoris;
– unstable angina pectoris (crescendo angina, angina at rest);
– vasospastic angina pectoris (Prinzmetal’s angina);
– angina after myocardial infarction in patients without heart failure, in case the use of beta-blockers is not indicated.
Verapamil-Tchaikapharma is indicated for the treatment of abnormal heart rhythm in paroxysmal supraventricular tachycardia and atrial fibrillation/flutter with rapid ventricular response except in Wolff-Parkinson-White or Lown-Ganang-Levine syndrome.
Verapamil-Tchaikapharma is indicated for treatment of high blood pressure hypertension.
Subject to medical prescription.
Concentration and pharmaceutical form: 80 mg coated tablets; 240 mg prolonged release tablets
Description
Bravylol contains nebivolol, a selective β1-blocker, which reduces heart rate, blood pressure and peripheral systemic vascular resistance.
Indications
Bravylol is indicated for the treatment of:
– essential hypertension;
– stable mild and moderate chronic heart failure in addition to standard therapies in elderly patients (>70 years).
Subject to medical prescription.
Concentration and pharmaceutical form: 5 mg tablets
